Distrobird — Free Sales Engagement Platform
Sequences, cloud call center, shared inbox, form tracking and more — on a single platform. Double your sales team's output with fewer tools.
Create a sequence — it's free
Xl Therapeutics Ltd.
xl therapeutics is a biopharmaceutical company aiming to develop small molecule compounds (smcs) to treat patients suffering from wiskott-aldrich syndrome (was) and x-linked thrombocytopenia (xlt), rare primary human immunodeficiencies that are caused by the absence or suboptimal function of the was protein (wasp). was is caused by a defect in an x-chromosome-linked gene encoding wasp. wasp, an adaptor protein expressed exclusively in hematopoietic cells, is essential for normal hematopoietic cell function, and its deficiencies lead to defects in proliferation, migration and overall activation of immune cells. the function of many hematopoietic lineages is affected by wasp deficiency. the more severe defects in wasp expression lead to was which includes varying degrees of thrombocytopenia, eczema, immunodeficiency, autoimmunity, and malignancy. less severe deficiencies in protein expression can lead to xlt where the primary defects are manifested in platelet dysfunction. was and xlt ea
Frequently asked questions about Xl Therapeutics Ltd.
Let us help answer the most common questions you might have.
Where is Xl Therapeutics Ltd. located?
Xl Therapeutics Ltd.'s headquarters is located at Illinois, United States
How many employees does Xl Therapeutics Ltd. have?
Xl Therapeutics Ltd. has 0 employees
What industry does Xl Therapeutics Ltd. belong to?
Xl Therapeutics Ltd. is in the industry of: Biotechnology
What are Xl Therapeutics Ltd.'s social media links?
Xl Therapeutics Ltd. Linkedin page
Distrobird — Free Sales Engagement Platform
Sequences, cloud call center, shared inbox, form tracking and more — on a single platform. Double your sales team's output with fewer tools.
Create a sequence — it's free